Identification of Novel Biomarkers of Spinal Muscular Atrophy and Therapeutic Response by Proteomic and Metabolomic Profiling of Human Biological Fluid Samples

Spinal muscular atrophy (SMA) is a neuromuscular disease resulting from mutations or deletions in SMN1 that lead to progressive death of alpha motor neurons, ultimately leading to severe muscle weakness and atrophy, as well as premature death in the absence of treatment. Recent approval of SMN-incre...

Descripción completa

Detalles Bibliográficos
Autores principales: Meneri, Megi, Abati, Elena, Gagliardi, Delia, Faravelli, Irene, Parente, Valeria, Ratti, Antonia, Verde, Federico, Ticozzi, Nicola, Comi, Giacomo P., Ottoboni, Linda, Corti, Stefania
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10215459/
https://www.ncbi.nlm.nih.gov/pubmed/37238925
http://dx.doi.org/10.3390/biomedicines11051254

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10215459/
https://www.ncbi.nlm.nih.gov/pubmed/37238925
http://dx.doi.org/10.3390/biomedicines11051254

Ejemplares similares